| Product Code: ETC8193965 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Malta import of hemostatic agents in 2024 continued to be sourced primarily from the Netherlands, UK, Germany, Italy, and Canada. Despite the concentrated source countries, the Herfindahl-Hirschman Index (HHI) indicated low concentration levels. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 20.99%, with a notable growth rate of 16.09% from 2023 to 2024. These trends suggest a steady expansion in Malta import market for hemostatic agents, driven by diverse sourcing and consistent growth rates.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Hemostatic Agents Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Hemostatic Agents Market - Industry Life Cycle |
3.4 Malta Hemostatic Agents Market - Porter's Five Forces |
3.5 Malta Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Malta Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Malta Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries and procedures requiring hemostatic agents in Malta |
4.2.2 Growing awareness about the importance of effective hemostasis in medical procedures |
4.2.3 Technological advancements leading to the development of more efficient hemostatic agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of hemostatic agents |
4.3.2 High costs associated with advanced hemostatic agents impacting adoption rates |
5 Malta Hemostatic Agents Market Trends |
6 Malta Hemostatic Agents Market, By Types |
6.1 Malta Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Malta Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Malta Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Malta Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Malta Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Malta Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Malta Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Malta Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Malta Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Malta Hemostatic Agents Market Export to Major Countries |
7.2 Malta Hemostatic Agents Market Imports from Major Countries |
8 Malta Hemostatic Agents Market Key Performance Indicators |
8.1 Rate of adoption of advanced hemostatic agents in hospitals and clinics |
8.2 Number of surgical procedures performed in Malta that require hemostatic agents |
8.3 Research and development investment in new hemostatic technologies |
9 Malta Hemostatic Agents Market - Opportunity Assessment |
9.1 Malta Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Malta Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Malta Hemostatic Agents Market - Competitive Landscape |
10.1 Malta Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Malta Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |